RxDoctor Payments DataLook up a doctor →

Todd Krehbiel, MD

Internal Medicine · Edmond, OKNPI 1467450692

Payments from drug & device makers

$20,907in general payments, 2019–2025

Across 1,150 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Amgen$2K
  • Bayer$1K
  • Pfizer$1K
  • plus $11K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)166$2,122
Novo Nordisk96$2,073
AstraZeneca66$1,842
Amgen(2 entities)62$1,603
Bayer73$1,140
Pfizer84$1,021
Takeda Pharmaceuticals U.S.A., Inc.57$978
GSK55$931
Lilly USA, LLC64$888
Boehringer Ingelheim51$848
Teva Pharmaceuticals USA, Inc.18$483
Daiichi Sankyo Inc.15$388
Johnson & Johnson16$351
Astellas Pharma US Inc4$339
Antares Pharma, Inc.11$290
Biohaven Pharmaceutical Holding Company Ltd.12$254
Merck19$231
Corcept Therapeutics14$226
Vistapharm, Inc.18$221
Arbor Pharmaceuticals, Inc.14$218
Otsuka America Pharmaceutical, Inc.10$216
Supernus Pharmaceuticals, Inc.16$207
Protega Pharmaceutials Inc13$201
Abbott10$199
Biohaven Pharmaceuticals, Inc.14$190
Mannkind Corporation9$188
Esperion Therapeutics, Inc.6$180
Jazz Pharmaceuticals Inc.9$171
Genentech USA, Inc.5$165
Phathom Pharmaceuticals, Inc.4$160
Medtronic(2 entities)2$155
Azurity Pharmaceuticals, Inc.9$146
Sanofi-aventis U.S. LLC9$134
Sumitomo Pharma America, Inc.6$126
Adlon Therapeutics L.p.8$125
Ironwood Pharmaceuticals, Inc7$112
Lundbeck LLC6$107
Axsome Therapeutics, Inc.4$100
Idorsia Pharmaceuticals US Inc5$93
Novartis4$90
Xeris Pharmaceuticals, Inc.5$90
Amarin Pharma, Inc.6$87
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$79
Acella Pharmaceuticals, LLC4$70
Neos Therapeutics, LP4$69
Ardelyx, Inc.3$67
Exact Sciences4$65
Gilead3$65
Corium, LLC4$64
Cequr Corporation2$58
VBI Vaccine (delaware) Inc.3$55
Kowa Pharmaceuticals America, Inc.3$49
Currax Pharmaceuticals LLC4$48
Viatris Specialty LLC2$44
Noven Therapeutics, LLC2$37
IBSA Pharma Inc.2$37
Boston Scientific1$37
Vanda Pharmaceuticals Inc.2$36
Nabriva Therapeutics, PLC2$34
Therapeuticsmd, Inc.2$34

How this compares

$20,907 in reported general payments places this provider in the 95th percentile of 840 internal medicine providers in Oklahoma.

See all internal medicine providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$196,435
Medicare patients
381
Services billed
3,312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Edmond

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →